SILEXION THERAPEUTICS CORP SLXN
SHS NEW · Common Stock · CUSIP G1281K122
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.81.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2024 | 4 |
| Q1 2025 | 6 |
| Q2 2025 | 7 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2025 | 4 | 1 |
| Q2 2025 | 3 | 1 |
Biggest buyers
| UBS Group AG | Added | +36.4k |
| Virtu Financial LLC | New | +14.3k |
| StoneX Group Inc. | New | +11.2k |
Biggest sellers
| SBI Securities Co., Ltd. | Sold out | -16.4k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Lincoln Alternative Strategies LLC 13G · passive investor new · filed 2025-09-15 | 6.2% |
Fell to 5% or below in the last year: Lind Global Fund III LP (5.0%, 2026-05-15)
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Wildcat Capital Management, LLC 0.05% of their portfolio | 113.4k $91.9k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 109.3k $88.5k | Added +36.4k |
| MEYER HANDELMAN CO 0.00% of their portfolio | 33.0k $26.7k | Unchanged |
| Virtu Financial LLC 0.00% of their portfolio | 14.3k $12.0k | New |
| StoneX Group Inc. 0.00% of their portfolio | 11.2k $9.1k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 500 $405 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |